News Channels

24 Mar 2018 Janssen Announces Positive CHMP Opinion for JULUCATM (dolutegravir/rilpivirine)
24 Mar 2018 CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets
24 Mar 2018 Portola Pharmaceuticals Receives and Plans to Appeal Negative CHMP Opinion Regarding Marketing Authorization for Betrixaban in the European Union
24 Mar 2018 Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS
24 Mar 2018 Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes
24 Mar 2018 OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes
24 Mar 2018 CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors
24 Mar 2018 Sandoz receives positive CHMP opinion for proposed biosimilar infliximab
24 Mar 2018 Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin®) For The Treatment Of Three Types Of Cancer
24 Mar 2018 TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe
23 Mar 2018 Lokelma approved in the EU for the treatment of adults with hyperkalaemia
23 Mar 2018 Anticancer Agent LENVIMA® (lenvatinib mesylate) Approved for Additional Indication of Unresectable Hepatocellular Carcinoma (HCC) in Japan, First Approval Worldwide for LENVIMA for HCC
23 Mar 2018 Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma
23 Mar 2018 vTv Therapeutics Announces Completion of Phase 1b Study Evaluating TTP399 for the Treatment of Type 1 Diabetes
23 Mar 2018 Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial
22 Mar 2018 ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)
22 Mar 2018 CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody
22 Mar 2018 Novartis drug Tasigna® approved by FDA to treat children with rare form of leukemia
22 Mar 2018 AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients with DLL3-Expressing Relapsed/Refractory Small Cell Lung Cancer
22 Mar 2018 Innate Biologics, LLC Enters Into Collaboration Agreement With The Wistar Institute to Develop Anti-Inflammatory Protein Platform

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing